RODAN & FIELDS PROACTIV SOLUTION: SKIN LIGHTENING LOTION 2 % — DIN 02250543
HYDROQUINONE : 2 % · GUTHY-RENKER LLC · LOTION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is RODAN & FIELDS PROACTIV SOLUTION: SKIN LIGHTENING LOTION?
RODAN & FIELDS PROACTIV SOLUTION: SKIN LIGHTENING LOTION 2 % contains HYDROQUINONE : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02250543, held by GUTHY-RENKER LLC, supplied as LOTION for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 01-Jul-2010. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Hydroquinone cost around the world?
Hydroquinone is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Iceland publishes a max wholesale; Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 13 | 18 | SAR███.██ |
| United Arab Emirates | public | 3 | 3 | AED███.██ |
| Bahrain | retail (max) | 2 | 3 | BHD███.██ |
| United States | acquisition | 1 | 3 | USD███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
28 pack listings across 20 brand entries and 4 price bases, refreshed 03 Sep 2026. Ranges span every Hydroquinone pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Hydroquinone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
33 holders have a Canadian DIN containing Hydroquinone, across 67 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SEARCHLIGHT PHARMA INC | 1 | 1 | ERFA HYDROQUINONE | Sourceable in Canada |
| VALEANT CANADA LP / VALEANT CANADA S.E.C. | 11 | 0 | ELDOPAQUE CRM 2%, ELDOPAQUE FORTE CRM 4%, ELDOQUIN, ELDOQUIN FORTE, ESOTERICA FACIAL CREAM, +6 more | No marketed DIN |
| KEYSTONE LABORATORIES INC. | 5 | 0 | ULTRA GLOW SKIN TONE CREAM DRY SKIN ALOE VERA, ULTRA GLOW SKIN TONE CREAM FOR NORMAL SKIN, ULTRA GLOW SKIN TONE CREAM FOR OILY SKIN, ULTRA GLOW SKIN TONE CREAM NORMAL SKIN ALOE VERA, ULTRA GLOW SKIN TONE CREAM OILY SKIN ALOE VERA | No marketed DIN |
| DRULA-FABRIK, DR. O. DRUCKERY GMBH | 4 | 0 | DRULA FADE CREAM EXTRA-MEDICATED, DRULA FADE CREAM MEDIUM-MEDICATED, DRULA FADE CREAM NORMAL-MEDICATED, DRULA FADE CREAM SUPERFORTE MEDICATED | No marketed DIN |
| VIVIER CANADA INCORPORATED | 4 | 0 | ACTIVE 4, CORRECTOR 4, SEEQUIN 4 IDS, SUNBALANCE | No marketed DIN |
| E.T. BROWNE DRUG CO., INC. | 3 | 0 | PALMER'S SKIN SUCCESS FADE CREAM-FOR DRY SKN, PALMER'S SKIN SUCCESS FADE CREAM-FOR OILY SK, PALMER'S SKIN SUCCESS FADE CREAM-NORMAL SKIN | No marketed DIN |
| NADINOLA INC. | 3 | 0 | NADINOLA SKIN DISC.FADE CRM FOR DRY SKIN 2%, NADINOLA SKIN DISC.FADE CRM FOR OILY SKIN 2%, NADINOLA SKIN DISCOLORATION FADE CREAM-S.C.F | No marketed DIN |
| SANOFI CONSUMER HEALTH INC | 3 | 0 | NEOSTRATA CANADA HQ PLUS CREAM, NEOSTRATA HQ PLUS LIGHTENING CREAM, ULTRAQUIN 4% HYDROQUINONE CREAM WITH SUNSCREENS | No marketed DIN |
| CONTINUUM | 2 | 0 | CONTINUUM UNIFYING LOTION I, CONTINUUM UNIFYING LOTION II | No marketed DIN |
| FLORI ROBERTS, INC. | 2 | 0 | DERMABLEND ADVANCED FADE CREAM WITH SUNSCREEN AND MOISTURIZING AHA, DERMABLEND CHROMATONE FADE CREAM WITH SUNSCREEN | No marketed DIN |
| LAVORIS-DEP CORPORATION | 2 | 0 | PORCELANA MEDICATED FADE CREAM - ORIG. FMLA, PORCELANA MEDICATED FADE CRM SUNSCREEN FMLA | No marketed DIN |
| OBAGI MEDICAL PRODUCTS A DIV OF VALEANT PHARMACEUTICALS NORTH AMERICA LLC | 2 | 0 | NUDERM SUNFADER, OBAGI PROTOCOLS CLEAR | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2 % |
|---|---|
| Dosage form | LOTION |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Hydroquinone |
|---|---|
| ATC code | D11AX11 |
| AHFS class | 84:50.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02250543 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2250543 |
| Brand name | RODAN & FIELDS PROACTIV SOLUTION: SKIN LIGHTENING LOTION |
| Generic / active ingredient | HYDROQUINONE : 2 % |
| Market authorization holder | GUTHY-RENKER LLC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AX11 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D11AX |
| Current status | CANCELLED POST MARKET |
| Status date | 01-Jul-2010 |
| Original market date | 2004-03-28 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 67 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ERFA HYDROQUINONE | 4 % | GEL | SEARCHLIGHT PHARMA INC | MARKETED | 02491702 |
| ACTIVE 4 | 4 % | CREAM | VIVIER CANADA INCORPORATED | CANCELLED POST MARKET | 02248851 |
| AFRICAN GOLD SKIN DISCOLORATION FADE CRM 2% | 2 % | CREAM | J. STRICKLAND & CO. | CANCELLED POST MARKET | 02029227 |
| AMBI EXTRA SKIN DISCOLORATION FADE CREAM | 2 % | CREAM | KIWI BRANDS INC. | CANCELLED POST MARKET | 02083337 |
| BANISHING CREAM | 2 % | CREAM | THE AVON COMPANY CANADA LIMITED | CANCELLED POST MARKET | 00602736 |
| BLACK OPAL ADVANCE DUAL COMPLEX FADE GEL | 2 % | GEL | BIOCOSMETIC RESEARCH LABS DIVISION OF MANA PRODUCTS INC. | CANCELLED (UNRETURNED ANNUAL) | 02240657 |
| BLACK OPAL ADVANCED DUAL PHASE FADE CREME | 2 % | CREAM | BIOCOSMETIC RESEARCH LABS DIVISION OF MANA PRODUCTS INC. | CANCELLED (UNRETURNED ANNUAL) | 02240656 |
| CLAIRISSIME CLEAR COMPLEXION LOTION | 2 % | LOTION | AYOTAI CANADA INC. | CANCELLED POST MARKET | 02251590 |
| CLEAR ESSENCE MEDICATED FADE CREAM | 2.5 % | CREAM | BLUEFIELD ASSOCIATES, INC. | CANCELLED (UNRETURNED ANNUAL) | 02239114 |
| CLEAR-N-SMOOTH | 2 % | CREAM | HAWKNAD MANUFACTURING INDUSTRIES, INC. | CANCELLED (UNRETURNED ANNUAL) | 02237828 |
2 · Same class — other molecules in ATC D11AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pyrithione Zinc | 2 IN 1 ANTI-DANDRUFF SHAMPOO AND CONDITIONER · 2 IN 1 CONDITIONING DANDRUFF SHAMPOO · 2 IN 1 CONDITIONING DANDRUFF TREATMENT SHAMPOO · 2 IN 1 DANDRUFF RELIEF SHAMPOO & CONDITIONER · +343 more | 363 | 67 | Yes |
| Finasteride | AURO-FINASTERIDE 1MG · FINASTERIDE · JAMP FINASTERIDE TABLETS · MINT-FINASTERIDE · +5 more | 10 | 8 | Yes |
| Minoxidil, Topical | APO-GAIN LIQ 20MG/ML · GEN-MINOXIDIL LIQ 2% · HAIR REGROWTH FORMULA · HAIR REGROWTH TREATMENT · +11 more | 16 | 7 | Yes |
| Ivermectin | PMS-IVERMECTIN · ROSIVER | 2 | 2 | Yes |
| Hydroquinone | ACTIVE 4 · AFRICAN GOLD SKIN DISCOLORATION FADE CRM 2% · AMBI EXTRA SKIN DISCOLORATION FADE CREAM · BANISHING CREAM · +63 more | 67 | 1 | Yes |
| Brimonidine | ONRELTEA | 1 | 1 | Yes |
| Eflornithine | VANIQA | 1 | 1 | Yes |
| Deoxycholic Acid | BELKYRA | 1 | 1 | Yes |
| Other Dermatologicals | DERMAGRAN II OINTMENT-ONT TOP 0.25% · SHUR-CLENS SOLN 20% · WITCH HAZEL | 3 | 0 | Not in Canada |
| Monobenzone | BENOQUIN CRM 20% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D11A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D11AH | Abrocitinib · Alitretinoin · Crisaborole · Delgocitinib · Dupilumab · +5 more | 25 | 19 |
| D11AF | Wart And Anti-Corn Preparations | 33 | 1 |
| D11AA | Antihidrotics | 397 | 0 |
| D11AC | Cetrimide · Medicated Shampoos · Others · Povidone-Iodine · Selenium Compounds · +1 more | 27 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is RODAN & FIELDS PROACTIV SOLUTION: SKIN LIGHTENING LOTION called?
The same molecule, Hydroquinone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| AVOQUIN | Latin | Bahrain, Saudi Arabia |
| HI-QUIN | Latin | Bahrain |
| AVOQUIN cream | Latin | Saudi Arabia |
| HI CARE CREAM | Latin | Saudi Arabia |
| HYDRODERM CREAM PLUS | Latin | Saudi Arabia |
| Hydroquinone Dawaa Health | Latin | Saudi Arabia |
| PIGMANORM | Latin | Saudi Arabia |
| PIGMANORM Creme Widmer | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.